-
Mashup Score: 2Analysis Shows ‘Superior’ GVHD Outcomes With Orca-T Prophylaxis Versus PTCy | Cancer Nursing Today - 11 day(s) ago
Patients who received Orca-T had “superior” all-grade chronic GVHD-free survival after allogeneic HSCT compared with those recieved PTCy.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Sexual Health Outcomes After CAR-T: Study Reveals 3 Major Themes | Cancer Nursing Today - 2 month(s) ago
The first study to evaluate sexual health outcomes in young adults receiving CAR T-cell therapy highlighted the need for improved patient-provider communication.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Analysis Shows ‘Superior’ GVHD Outcomes With Orca-T Prophylaxis Versus PTCy | Cancer Nursing Today - 2 month(s) ago
Patients who received Orca-T had “superior” all-grade chronic GVHD-free survival after allogeneic HSCT compared with those recieved PTCy.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Nurse Navigator Transition Visits After HSCT Improve Survivor Knowledge of GVHD | Cancer Nursing Today - 2 month(s) ago
Transition visits from a nurse navigator after allogeneic hematopoietic stem cell transplant improved patient confidence about graft-versus-host-disease in multiple domains.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1What Happens When aGVHD Occurs After PTCy? New Study Provides Insights on Outcomes | Cancer Nursing Today - 2 month(s) ago
When acute graft-versus-host-disease (aGVHD) occurs after post-transplant cyclophosphamide (PTCy)-based prophylaxis, it is “predominantly” steroid-sensitive aGVHD.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5
Lisocabtagene maraleucel given as a single administration led to rapid responses in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Nurse Navigator Transition Visits After HSCT Improve Survivor Knowledge of GVHD | Cancer Nursing Today - 2 month(s) ago
Transition visits from a nurse navigator after allogeneic hematopoietic stem cell transplant improved patient confidence about graft-versus-host-disease in multiple domains.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 42024 Tandem Meetings | Blood Cancers Today - 2 month(s) ago
The 2024 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR feature the latest updates in hematopoietic stem cell transplantation and cellular therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Advancements in CAR T, GVHD Shine at 2024 TCT Tandem Meetings - 2 month(s) ago
The latest developments across the fields of stem cell transplantation and cellular therapy were presented at the 2024 Tandem Meetings in San Antonio, Texas, from February 21-24, 2024.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Minimizing Sleep Disruptions for Children Recovering From HSCT: A Nursing Perspective | Cancer Nursing Today - 3 month(s) ago
It is “crucial” for hospitals to “assess and remediate” noise and light disturbances for children who are recovering from hematopoietic stem cell transplant.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
🤔 How does Orca-T compare to PTCy-based GVHD prophylaxis in patients receiving allogeneic HSCT from matched unrelated donors? 📰 Research presented at #Tandem24 by @AGomez_MD of @WeillCornell, @nyphospital provided insights. ➡️ Learn more: https://t.co/rwYsfn7ieB https://t.co/yGp0LtuaMe